Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Association of Concussion With the Risk of Suicide: A Systematic Review and Meta-Analysis.

Fralick M, Sy E, Hassan A, Burke MJ, Mostofsky E, Karsies T.

JAMA Neurol. 2018 Nov 12. doi: 10.1001/jamaneurol.2018.3487. [Epub ahead of print]

PMID:
30419085
2.

Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Amputation: Results and Challenges From the Real World.

Fralick M, Patorno E, Fischer MA.

JAMA Intern Med. 2018 Sep 1;178(9):1199-1200. doi: 10.1001/jamainternmed.2018.3025. No abstract available.

PMID:
30105365
3.

Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence.

Mir H, Siemieniuk RAC, Ge LC, Foroutan F, Fralick M, Syed T, Lopes LC, Kuijpers T, Mas JL, Vandvik PO, Agoritsas T, Guyatt GH.

BMJ Open. 2018 Jul 25;8(7):e023761. doi: 10.1136/bmjopen-2018-023761. Erratum in: BMJ Open. 2018 Aug 17;8(8):e023761corr1.

4.

The Shortage of Normal Saline in the Wake of Hurricane Maria.

Sacks CA, Kesselheim AS, Fralick M.

JAMA Intern Med. 2018 Jul 1;178(7):885-886. doi: 10.1001/jamainternmed.2018.1936. No abstract available.

PMID:
29799949
5.

Application and Impact of Run-In Studies for the Evaluation of Statin Efficacy and Safety.

Fralick M, Avorn J, Franklin JM, Bartsch E, Abdurrob A, Kesselheim AS.

J Gen Intern Med. 2018 Jun;33(6):792-794. doi: 10.1007/s11606-018-4349-2. No abstract available.

PMID:
29520746
6.

Risk of early-onset breast cancer among women exposed to thoracic computed tomography in pregnancy or early postpartum.

Burton KR, Park AL, Fralick M, Ray JG.

J Thromb Haemost. 2018 May;16(5):876-885. doi: 10.1111/jth.13980. Epub 2018 Mar 23.

PMID:
29450965
7.

Application and impact of run-in studies.

Fralick M, Avorn J, Franklin JM, Abdurrob A, Kesselheim AS.

J Gen Intern Med. 2018 May;33(5):759-763. doi: 10.1007/s11606-018-4344-7. Epub 2018 Feb 15.

PMID:
29450684
8.

Can a smartphone app improve medical trainees' knowledge of antibiotics?

Fralick M, Haj R, Hirpara D, Wong K, Muller M, Matukas L, Bartlett J, Leung E, Taggart L.

Int J Med Educ. 2017 Nov 30;8:416-420. doi: 10.5116/ijme.5a11.8422.

9.

Use of Health Care Databases to Support Supplemental Indications of Approved Medications.

Fralick M, Kesselheim AS, Avorn J, Schneeweiss S.

JAMA Intern Med. 2018 Jan 1;178(1):55-63. doi: 10.1001/jamainternmed.2017.3919.

10.

The Price of Crossing the Border for Medications.

Fralick M, Avorn J, Kesselheim AS.

N Engl J Med. 2017 Oct 26;377(17):1699-1700. doi: 10.1056/NEJMc1711278. No abstract available.

PMID:
29069557
11.

Low-Dose Desmopressin Nasal Spray and FDA Approval-Reply.

Fralick M, Kesselheim AS.

JAMA. 2017 Sep 19;318(11):1071-1072. doi: 10.1001/jama.2017.11343. No abstract available.

PMID:
28975301
12.

Bariatric surgery.

Rohailla S, Jackson TD, Fralick M.

CMAJ. 2017 Aug 8;189(31):E1017. doi: 10.1503/cmaj.170339. No abstract available.

13.

The Price of Crossing the Border for Medications.

Fralick M, Avorn J, Kesselheim AS.

N Engl J Med. 2017 Jul 27;377(4):311-313. doi: 10.1056/NEJMp1704489. No abstract available.

14.

Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor.

Fralick M, Schneeweiss S, Patorno E.

N Engl J Med. 2017 Jun 8;376(23):2300-2302. doi: 10.1056/NEJMc1701990. No abstract available.

15.

Sodium-glucose cotransporter 2 inhibitors for treating diabetes mellitus.

Goldberg N, Fralick M.

CMAJ. 2017 May 23;189(20):E724. doi: 10.1503/cmaj.161455. No abstract available.

16.

REDucing Unnecessary Coagulation Testing in the Emergency Department (REDUCED).

Fralick M, Hicks LK, Chaudhry H, Goldberg N, Ackery A, Nisenbaum R, Sholzberg M.

BMJ Qual Improv Rep. 2017 May 2;6(1). pii: u221651.w8161. doi: 10.1136/bmjquality.u221651.w8161. eCollection 2017.

17.

Three design aspects for high quality post-marketing cohort studies.

Fralick M, Kesselheim AS.

BMJ. 2017 Apr 12;357:j1851. doi: 10.1136/bmj.j1851. No abstract available.

PMID:
28404570
18.

Coagulation Testing in a Bleeding Patient.

Fralick M, Sholzberg M.

JAMA. 2017 Apr 11;317(14):1478-1479. doi: 10.1001/jama.2017.2416. No abstract available.

PMID:
28399241
19.

FDA Approval of Desmopressin for Nocturia.

Fralick M, Kesselheim AS.

JAMA. 2017 May 23;317(20):2059-2060. doi: 10.1001/jama.2017.4316. No abstract available.

PMID:
28384655
20.

Periodic benefit-risk evaluation reports have substantial promise to guide patient care and should be made publicly available.

Fralick M, Kesselheim AS.

Pharmacoepidemiol Drug Saf. 2017 May;26(5):597-599. doi: 10.1002/pds.4177. Epub 2017 Feb 15. No abstract available.

PMID:
28198116
21.

Applying Academic Detailing and Process Change to Promote Choosing Wisely.

Fralick M, Kesselheim A, Avorn J.

JAMA Intern Med. 2017 Feb 1;177(2):282. doi: 10.1001/jamainternmed.2016.8503. No abstract available.

PMID:
28166340
22.

Lead toxicity from glazed ceramic cookware.

Fralick M, Thomspson A, Mourad O.

CMAJ. 2016 Dec 6;188(17-18):E521-E524. Epub 2016 Oct 17. No abstract available.

23.

Toxic Alcohol Calculations and Misinterpretation Of Laboratory Results-Reply.

Fralick M, Lam K, Himmel ME.

JAMA Intern Med. 2016 Aug 1;176(8):1229-30. doi: 10.1001/jamainternmed.2016.3729. No abstract available.

PMID:
27479670
24.

Concussions and suicide.

Redelmeier DA, Tien HC, Fralick M.

CMAJ. 2016 May 17;188(8):605. doi: 10.1503/cmaj.1150102. No abstract available.

25.

Training the trainer: five practical considerations for your first five years in practice.

Jacobs C, Joy AA, Clemons M, Mazzarello S, Fralick M.

Curr Oncol. 2016 Apr;23(2):71-3. doi: 10.3747/co.23.2959. Epub 2016 Apr 13. No abstract available.

26.

A simple approach for eliminating spam.

Mazzarello S, Fralick M, Clemons M.

Curr Oncol. 2016 Feb;23(1):e75-6. doi: 10.3747/co.23.2860. Epub 2016 Feb 18. No abstract available.

27.

Hemodialysis in a Healthy Patient--A Case of an Erroneous Laboratory Result: A Teachable Moment.

Himmel ME, Lam K, Fralick M.

JAMA Intern Med. 2016 Apr;176(4):431-2. doi: 10.1001/jamainternmed.2015.8447. No abstract available. Erratum in: JAMA Intern Med. 2016 Jul 1;176(7):1037.

PMID:
26903235
28.

Risk of suicide after a concussion.

Fralick M, Thiruchelvam D, Tien HC, Redelmeier DA.

CMAJ. 2016 Apr 19;188(7):497-504. doi: 10.1503/cmaj.150790. Epub 2016 Feb 8.

29.

Bleeding associated with coadministration of rivaroxaban and clarithromycin.

Fralick M, Juurlink DN, Marras T.

CMAJ. 2016 Jun 14;188(9):669-72. doi: 10.1503/cmaj.150580. Epub 2016 Jan 25. No abstract available.

30.

Hepatitis C virus infection.

Fralick M, Feld JJ.

CMAJ. 2015 Oct 20;187(15):1159. doi: 10.1503/cmaj.140290. Epub 2015 Aug 24. No abstract available.

31.

Publishing clinical research: ten pearls for oncology trainees and junior oncologists.

Mazzarello S, Clemons M, Jacobs C, Arnaout A, Fralick M.

Curr Oncol. 2015 Feb;22(1):e1-5. doi: 10.3747/co.22.2258. No abstract available.

32.

Authors' reply to Scheper and Lijfering.

Fralick M, Juurlink DN.

BMJ. 2014 Nov 18;349:g6906. doi: 10.1136/bmj.g6906. No abstract available.

PMID:
25406180
33.

In search of evidence-based treatment for concussion: characteristics of current clinical trials.

Burke MJ, Fralick M, Nejatbakhsh N, Tartaglia MC, Tator CH.

Brain Inj. 2015;29(3):300-5. doi: 10.3109/02699052.2014.974673. Epub 2014 Nov 10. Review.

34.

Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study.

Fralick M, Macdonald EM, Gomes T, Antoniou T, Hollands S, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network.

BMJ. 2014 Oct 30;349:g6196. doi: 10.1136/bmj.g6196.

35.

Ethnic Differences in Drowning Rates in Ontario, Canada.

Gallinger ZR, Fralick M, Hwang SW.

J Immigr Minor Health. 2015 Oct;17(5):1436-43. doi: 10.1007/s10903-014-0095-7.

PMID:
25187321
36.

Physician burnout: who will protect us from ourselves?

Fralick M, Flegel K.

CMAJ. 2014 Jul 8;186(10):731. doi: 10.1503/cmaj.140588. Epub 2014 Jun 2. No abstract available.

37.

Screening urged for hepatitis C but drug costs are prohibitive.

Fralick M.

CMAJ. 2014 Mar 18;186(5):329. doi: 10.1503/cmaj.109-4727. Epub 2014 Feb 18. No abstract available.

38.

Putting patients first in the age of pharma.

Fralick M.

CMAJ. 2014 Mar 4;186(4):253. doi: 10.1503/cmaj.109-4716. Epub 2014 Feb 10. No abstract available.

39.

Bevacizumab for advanced breast cancer: hope, hype, and hundreds of headlines.

Fralick M, Ray M, Fung C, Booth CM, Mallick R, Clemons MJ.

Oncologist. 2013;18(11):1174-9. doi: 10.1634/theoncologist.2013-0160. Epub 2013 Sep 26.

40.

Drowning and the influence of hot weather.

Fralick M, Denny CJ, Redelmeier DA.

PLoS One. 2013 Aug 14;8(8):e71689. doi: 10.1371/journal.pone.0071689. eCollection 2013.

41.

Histomorphometric and microarchitectural analyses using the 2 mm bone marrow trephine in metastatic breast cancer patients-preliminary results.

Fralick M, Bouganim N, Kremer R, Kekre N, Robertson S, Vandermeer L, Kuchuk I, Li J, Murshed M, Clemons M.

J Bone Oncol. 2012 Dec 1;1(3):69-73. doi: 10.1016/j.jbo.2012.10.003. eCollection 2012 Dec.

42.

Dual blockade of HER2 - twice as good or twice as toxic?

Fralick M, Hilton JF, Bouganim N, Clemons M, Amir E.

Clin Oncol (R Coll Radiol). 2012 Nov;24(9):593-603. doi: 10.1016/j.clon.2012.05.009. Epub 2012 Jun 28. Review.

PMID:
22748560
43.

Presentation of nonfinal results of randomized controlled trials at major oncology meetings.

Booth CM, Le Maître A, Ding K, Farn K, Fralick M, Phillips C, Cescon DW, Meyer RM.

J Clin Oncol. 2009 Aug 20;27(24):3938-44. doi: 10.1200/JCO.2008.18.8771. Epub 2009 Jul 20.

PMID:
19620490
44.

Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients.

Freedman O, Amir E, Dranitsaris G, Napolskikh J, Kumar R, Fralick M, Chia S, Petrella T, Dent S, Tonkin K, Ahmad I, Rayson D, Clemons M.

Breast Cancer Res Treat. 2009 Nov;118(2):377-83. doi: 10.1007/s10549-009-0452-8. Epub 2009 Jun 24.

PMID:
19551499
45.

Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design.

Kassam F, Enright K, Dent R, Dranitsaris G, Myers J, Flynn C, Fralick M, Kumar R, Clemons M.

Clin Breast Cancer. 2009 Feb;9(1):29-33. doi: 10.3816/CBC.2009.n.005.

PMID:
19299237
46.

Radiological changes following second-line zoledronic acid treatment in breast cancer patients with bone metastases.

Amir E, Whyne C, Freedman OC, Fralick M, Kumar R, Hardisty M, Clemons M.

Clin Exp Metastasis. 2009;26(5):479-84. doi: 10.1007/s10585-009-9247-x. Epub 2009 Mar 6.

PMID:
19266291
47.

External influences and priority-setting for anti-cancer agents: a case study of media coverage in adjuvant trastuzumab for breast cancer.

Booth CM, Dranitsaris G, Gainford MC, Berry S, Fralick M, Fralick J, Sue J, Clemons M.

BMC Cancer. 2007 Jun 28;7:110. Review.

Supplemental Content

Loading ...
Support Center